Epigenetic basis of diabetic vasculopathy.

Front Endocrinol (Lausanne)

Department of Surgery, Indiana Center for Regenerative Medicine and Engineering, Indiana University School of Medicine, Indianapolis, IN, United States.

Published: December 2022

Type 2 diabetes mellitus (T2DM) causes peripheral vascular disease because of which several blood-borne factors, including vital nutrients fail to reach the affected tissue. Tissue epigenome is sensitive to chronic hyperglycemia and is known to cause pathogenesis of micro- and macrovascular complications. These vascular complications of T2DM may perpetuate the onset of organ dysfunction. The burden of diabetes is primarily because of a wide range of complications of which nonhealing diabetic ulcers represent a major component. Thus, it is imperative that current research help recognize more effective methods for the diagnosis and management of early vascular injuries. This review addresses the significance of epigenetic processes such as DNA methylation and histone modifications in the evolution of macrovascular and microvascular complications of T2DM.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780391PMC
http://dx.doi.org/10.3389/fendo.2022.989844DOI Listing

Publication Analysis

Top Keywords

complications t2dm
8
epigenetic basis
4
basis diabetic
4
diabetic vasculopathy
4
vasculopathy type
4
type diabetes
4
diabetes mellitus
4
mellitus t2dm
4
t2dm peripheral
4
peripheral vascular
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!